http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110742870-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
filingDate | 2019-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110742870-B |
titleOfInvention | Abiraterone acetate preparation and preparation method thereof |
abstract | The invention belongs to the technical field of medicines, and particularly relates to an abiraterone acetate preparation and a preparation method thereof. The abiraterone acetate preparation disclosed by the invention contains not only abiraterone acetate, but also glutathione and L-malic acid, wherein in every 1000 preparation units, the dosage of the abiraterone acetate is 250g, the dosage of the glutathione is 100g, and the dosage of the L-malic acid is 15 g. The abiraterone acetate preparation disclosed by the invention is small in auxiliary material dosage, simple in preparation process, good in solubility and stable in quality. |
priorityDate | 2019-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.